| Catalytic in vivo protein knockdown by small-molecule PROTACs DP Bondeson, A Mares, IED Smith, E Ko, S Campos, AH Miah, ... Nature chemical biology 11 (8), 611-617, 2015 | 1476 | 2015 |
| Lessons in PROTAC design from selective degradation with a promiscuous warhead DP Bondeson, BE Smith, GM Burslem, AD Buhimschi, J Hines, ... Cell chemical biology 25 (1), 78-87. e5, 2018 | 974 | 2018 |
| The advantages of targeted protein degradation over inhibition: an RTK case study GM Burslem, BE Smith, AC Lai, S Jaime-Figueroa, DC McQuaid, ... Cell chemical biology 25 (1), 67-77. e3, 2018 | 737 | 2018 |
| Targeted protein degradation by small molecules DP Bondeson, CM Crews Annual review of pharmacology and toxicology 57 (1), 107-123, 2017 | 230 | 2017 |
| Targeting BCR-ABL1 in chronic myeloid leukemia by PROTAC-mediated targeted protein degradation GM Burslem, AR Schultz, DP Bondeson, CA Eide, SL Savage Stevens, ... Cancer research 79 (18), 4744-4753, 2019 | 214 | 2019 |
| In vivo Drosophilia genetic model for calcium oxalate nephrolithiasis T Hirata, P Cabrero, DS Berkholz, DP Bondeson, EL Ritman, ... American Journal of Physiology-Renal Physiology 303 (11), F1555-F1562, 2012 | 70 | 2012 |
| Phosphate dysregulation via the XPR1–KIDINS220 protein complex is a therapeutic vulnerability in ovarian cancer DP Bondeson, BR Paolella, A Asfaw, MV Rothberg, TA Skipper, ... Nature cancer 3 (6), 681-695, 2022 | 67 | 2022 |
| Systematic profiling of conditional degron tag technologies for target validation studies DP Bondeson, Z Mullin-Bernstein, S Oliver, TA Skipper, TC Atack, N Bick, ... Nature communications 13 (1), 5495, 2022 | 50 | 2022 |
| Ion and solute transport by Prestin in Drosophila and Anopheles T Hirata, A Czapar, L Brin, A Haritonova, DP Bondeson, P Linser, ... Journal of insect physiology 58 (4), 563-569, 2012 | 39 | 2012 |
| Scaffold hopping enables direct access to more potent PROTACs with in vivo activity GM Burslem, DP Bondeson, CM Crews Chemical Communications 56 (50), 6890-6892, 2020 | 35 | 2020 |
| An In Vitro Pull-down Assay of the E3 Ligase: PROTAC: Substrate Ternary Complex to Identify Effective PROTACs DP Bondeson, BE Smith, AD Buhimschi Targeted Protein Degradation: Methods and Protocols, 135-150, 2021 | 3 | 2021 |
| Insights into phosphate homeostasis regulation by XPR1 DP Bondeson Nature Structural & Molecular Biology 32 (1), 5-7, 2025 | 2 | 2025 |
| Molecular insights into KIAA1549:: BRAF fusion proteins: Implications for targeted therapy in pediatric low-grade gliomas D Christen, S Misek, A Borgenvik, G Kyrila, A Zhang, S Reel, M Boisvert, ... CANCER RESEARCH 85 (18), 2025 | | 2025 |
| Abstract A032: Molecular insights into KIAA1549:: BRAF fusion proteins: Implications for targeted therapy in pediatric low-grade gliomas D Christen, S Misek, A Borgenvik, G Kyrila, A Zhang, S Reel, M Boisvert, ... Cancer Research 85 (18_Supplement_2), A032-A032, 2025 | | 2025 |
| Abstract B019: O-mannosylation represents a therapeutic opportunity in BRAF fusion protein oncogenesis A Borgenvik, S Misek, D Christen, G Kyrila, A Zhang, S Reel, M Boisvert, ... Cancer Research 85 (18_Supplement_2), B019-B019, 2025 | | 2025 |
| O-mannosylation and protein maturation check-points represent therapeutic opportunities in BRAF fusion protein oncogenesis SA Misek, A Borgenvik, D Christen, G Kyrila, A Zhang, S Reel, M Boisvert, ... bioRxiv, 2025.08. 18.670743, 2025 | | 2025 |
| Discovery of chromatin-based determinants of azacytidine and decitabine anti-cancer activity RV Puram, Q Yin, YJ Liu, JC Rutter, D Bondeson, MC Saberi, L Miller, ... bioRxiv, 2025 | | 2025 |
| Therapeutic targeting of inositol pyrophosphate synthesis in cancer T Golub, D Bondeson US Patent App. 19/002,178, 2025 | | 2025 |
| LGG-26. A ROLE FOR BRAF FUSION PARTNERS IN ONCOGENIC SIGNALING S Misek, A Borgenvik, R Fekade, A Zhang, T Ragnoni, A Fultineer, K Zhou, ... Neuro-Oncology 26 (Suppl 4), 0, 2024 | | 2024 |
| LGG-29. BEYOND MAPK SIGNALING-GENOME-SCALE CRISPR/CAS9 SCREENS REVEAL NEW TARGETS FOR TREATMENT OF KIAA1549:: BRAF-DRIVEN PEDIATRIC LOW-GRADE GLIOMA A Borgenvik, S Misek, A Zhang, R Fekade, T Ragnoni, A Fultineer, K Zhou, ... Neuro-Oncology 26 (Suppl 4), 0, 2024 | | 2024 |
